Research ExplorerScientific StaffSusanna Carolina Berger Publications

Dr.med. ID: 6360130

Susanna Carolina Berger

Group leader

graph of relations
Affiliations
Emails
Phone: 0049-40-7410-55917
ORCID: 0000-0001-9403-5957
1 - 50 out of 53Page size: 50

Publications

  1. 2024

  2. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

    Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., Borie, D., Seibel, J., Ayuk, F., Friese, M. A., Heesen, C. & Kröger, N., 14.06.2024, In: MED-CAMBRIDGE. 5, 6, p. 550-558.e2

    Research output: SCORING: Contribution to journal › Case report › Research › peer-review

  3. 2023

  4. Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients

    Gagelmann, N., Ayuk, F. A., Klyuchnikov, E., Wolschke, C., Berger, S. C. & Kröger, N., 01.10.2023, In: HAEMATOLOGICA. 108, 10, p. 2799-2802 4 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  5. Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients

    Panagiota, V., Kerschbaum, J. F., Penack, O., Stein, C. M., Arends, C. M., Koenecke, C., Strzelecka, P. M., Kloos, A., Wiegand, L., Lasch, A., Altwasser, R., Halik, A., Gabdoulline, R., Thomson, J., Weibl, K., Franke, G-N., Berger, C., Hasenkamp, J., Ayuk, F., Na, I-K., Beutel, G., Keller, U., Bullinger, L., Wulf, G. G., Kröger, N., Vucinic, V., Heuser, M. & Damm, F., 10.2023, In: HEMASPHERE. 7, 10, p. e957

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation

    Gagelmann, N., Wolschke, C., Badbaran, A., Janson, D., Berger, C., Klyuchnikov, E., Ayuk, F., Fehse, B. & Kröger, N., 07.2023, In: HEMASPHERE. 7, 7, p. e921

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor-T cell therapy

    Berger, S. C., Fehse, B., Akyüz, N., Geffken, M., Wolschke, C., Janson, D., Gagelmann, N., Luther, M., Wichmann, D., Frenzel, C., Thayssen, G., Alegiani, A., Badbaran, A., Zeschke, S., Dierlamm, J., Kröger, N. & Ayuk, F. A., 01.02.2023, In: HAEMATOLOGICA. 108, 2, p. 444-456 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2022

  9. Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients

    Schubert, M-L., Berger, C., Kunz, A., Schmitt, A., Badbaran, A., Neuber, B., Zeschke, S., Wang, L., Riecken, K., Hückelhoven-Krauss, A., Müller, I., Müller-Tidow, C., Dreger, P., Kröger, N., Ayuk, F. A., Schmitt, M. & Fehse, B., 05.2022, In: INT J ONCOL. 60, 5, 48.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Immune Monitoring

    Berger, S. C., Fehse, B. & Rubio, M-T., 2022, The EBMT/EHA CAR-T Cell Handbook. Kröger, N., Gribben, J., Chabannon, C., Yakoub-Agha, I. & Einsele, H. (eds.). 1 ed. Cham: Springer International Publishing, p. 177-182 6 p.

    Research output: SCORING: Contribution to book/anthology › Chapter › Research

  11. 2021

  12. CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma

    Rejeski, K., Perez Perez, A., Sesques, P., Hoster, E., Berger, C. S., Jentzsch, L., Mougiakakos, D., Frölich, L., Ackermann, J., Buecklein, V., Blumenberg, V., Schmidt, C., Jallades, L., Fehse, B., Faul, C., Karschnia, P., Weigert, O., Dreyling, M., Locke, F. L., von Bergwelt-Baildon, M., Mackensen, A., Bethge, W. A., Ayuk, F., Bachy, E., Salles, G. A., Jain, M. D. & Subklewe, M., 16.12.2021, In: BLOOD. 138, 24, p. 2499-2513 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting

    Ayuk, F. A., Berger, C., Badbaran, A., Zabelina, T., Sonntag, T., Riecken, K., Geffken, M., Wichmann, D., Frenzel, C., Thayssen, G., Zeschke, S., Kröger, N. & Fehse, B., 08.06.2021, In: BLOOD ADV. 5, 11, p. 2523-2527 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Immunogenic chemotherapy enhances recruitment of CAR-T cells to lung tumors and improves antitumor efficacy when combined with checkpoint blockade

    Srivastava, S., Furlan, S. N., Jaeger-Ruckstuhl, C., Sarvothama, M., Berger, S. C., Smythe, K. S., Garrison, S. M., Specht, J. M., Lee, S. M., Amezquita, R. A., Viollet, V., Muhunthan, V., Yechan-Gunja, S., Pillai, S. PS., Rader, C., Houghton, A. M., Pierce, R. H., Gottardo, R., Maloney, D. G. & Riddell, S. R., 08.02.2021, In: CANCER CELL. 39, 2, p. 193-208.e10

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2020

  16. Development of CAR-T cell therapies for multiple myeloma

    Gagelmann, N., Riecken, K., Wolschke, C., Berger, C., Ayuk, F. A., Fehse, B. & Kröger, N., 09.2020, In: LEUKEMIA. 34, 9, p. 2317-2332 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  17. Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCR

    Badbaran, A., Berger, C., Riecken, K., Kruchen, A., Geffken, M., Müller, I., Kröger, N., Ayuk, F. A. & Fehse, B., 20.07.2020, In: CANCERS. 12, 7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Excellent proliferation and persistence of allogeneic donor-derived 41-BB based CAR-T cells despite immunosuppression with cyclosporine A

    Ayuk, F., Fehse, B., Janson, D., Berger, C., Riecken, K. & Kröger, N., 06.2020, In: HAEMATOLOGICA. 105, 6, p. 322-324 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  19. Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel

    Fehse, B., Badbaran, A., Berger, C., Sonntag, T., Riecken, K., Geffken, M., Kröger, N. & Ayuk, F. A., 13.03.2020, In: MOL THER-METH CLIN D. 16, p. 172-178 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. 2019

  21. Chancen und Risiken der CAR-T-Zell-Therapie

    Ayuk, F. A., Fehse, B., Berger, S. C., Riecken, K. & Kroger, N., 10.2019, In: Hamb Ärztebl. 73, 10, p. 30-32

    Research output: SCORING: Contribution to journal › SCORING: Review article › Education

  22. 2018

  23. Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates

    Taraseviciute, A., Tkachev, V., Ponce, R., Turtle, C. J., Snyder, J. M., Liggitt, H. D., Myerson, D., Gonzalez-Cuyar, L., Baldessari, A., English, C., Yu, A., Zheng, H., Furlan, S. N., Hunt, D. J., Hoglund, V., Finney, O., Brakke, H., Blazar, B. R., Berger, C., Riddell, S. R., Gardner, R., Kean, L. S. & Jensen, M. C., 06.2018, In: CANCER DISCOV. 8, 6, p. 750-763 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Compositions and Methods of Immunotherapy Targeting Tigit and/or CD112R.

    Riddell, S. R., Berger, S. C. & Srivastava, S., 2018, IPC No. A61K 39/00, Patent No. WO 2019/079777 Al, 19.10.2018, Priority date 20.10.2017, Priority No. 62/575,326

    Research output: Patent

  25. 2017

  26. Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues

    Balakrishnan, A., Goodpaster, T., Randolph-Habecker, J., Hoffstrom, B. G., Jalikis, F. G., Koch, L. K., Berger, C., Kosasih, P. L., Rajan, A., Sommermeyer, D., Porter, P. L. & Riddell, S. R., 15.06.2017, In: CLIN CANCER RES. 23, 12, p. 3061-3071 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility

    Künkele, A., Taraseviciute, A., Finn, L. S., Johnson, A. J., Berger, C., Finney, O., Chang, C. A., Rolczynski, L. S., Brown, C., Mgebroff, S., Berger, M., Park, J. R. & Jensen, M. C., 15.01.2017, In: CLIN CANCER RES. 23, 2, p. 466-477 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. 2016

  29. Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells

    Turtle, C. J., Hanafi, L-A., Berger, C., Hudecek, M., Pender, B., Robinson, E., Hawkins, R., Chaney, C., Cherian, S., Chen, X., Soma, L., Wood, B., Li, D., Heimfeld, S., Riddell, S. R. & Maloney, D. G., 07.09.2016, In: SCI TRANSL MED. 8, 355, p. 355ra116

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

    Turtle, C. J., Hanafi, L-A., Berger, C., Gooley, T. A., Cherian, S., Hudecek, M., Sommermeyer, D., Melville, K., Pender, B., Budiarto, T. M., Robinson, E., Steevens, N. N., Chaney, C., Soma, L., Chen, X., Yeung, C., Wood, B., Li, D., Cao, J., Heimfeld, S., Jensen, M. C., Riddell, S. R. & Maloney, D. G., 01.06.2016, In: J CLIN INVEST. 126, 6, p. 2123-38 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Comparison of naïve and central memory derived CD8+ effector cell engraftment fitness and function following adoptive transfer

    Wang, X., Wong, C. W., Urak, R., Taus, E., Aguilar, B., Chang, W-C., Mardiros, A., Budde, L. E., Brown, C. E., Berger, C., Forman, S. J. & Jensen, M. C., 05.03.2016, In: ONCOIMMUNOLOGY. 5, 1, p. e1072671

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 2015

  33. Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells

    Berger, C., Sommermeyer, D., Hudecek, M., Berger, M., Balakrishnan, A., Paszkiewicz, P. J., Kosasih, P. L., Rader, C. & Riddell, S. R., 02.2015, In: CANCER IMMUNOL RES. 3, 2, p. 206-16 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Immune cell therapy.

    Berger, S. C. & Riddell, S. R., 2015, Williams Hematology. Kaushansky, K., Lichtman, M. A., Prchal, J. T., Levi, M. M., Press, O. W., Burns, L. J. & Caliguri, M. A. (eds.). 9 ed. USA: McGraw-Hill, New York, p. 409-420 12 p.

    Research output: SCORING: Contribution to book/anthology › Chapter › Research › peer-review

  35. 2014

  36. Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition

    Riddell, S. R., Sommermeyer, D., Berger, C., Liu, L. S., Balakrishnan, A., Salter, A., Hudecek, M., Maloney, D. G. & Turtle, C. J., 29.03.2014, In: CANCER J. 20, 2, p. 141-4 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  37. Adoptive Transfer of CD8+ T Cell Clones Derived from Central Memory Cells.

    Riddell, S. R., Berger, S. C. & Jensen, M. C., 2014, IPC No. C12N 5/0638, Patent No. US10,400,215B2, 12.06.2014

    Research output: Patent

  38. Compositions and Methods for Boosting the Efficacy of Adoptive Cellular Immunotherapy.

    Berger, F. & Riddell, S. R., 2014, IPC No. A61K 39/00, Patent No. WO 2016/069647 Al, 27.10.2014

    Research output: Patent

  39. 2013

  40. Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma

    Budde, L. E., Berger, C., Lin, Y., Wang, J., Lin, X., Frayo, S. E., Brouns, S. A., Spencer, D. M., Till, B. G., Jensen, M. C., Riddell, S. R. & Press, O. W., 2013, In: PLOS ONE. 8, 12, p. e82742

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques

    Berger, C., Berger, M., Beard, B. C., Kiem, H-P., Gooley, T. A. & Riddell, S. R., 2013, In: PLOS ONE. 8, 2, p. e56268

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. 2012

  43. New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer

    Stroncek, D. F., Berger, C., Cheever, M. A., Childs, R. W., Dudley, M. E., Flynn, P., Gattinoni, L., Heath, J. R., Kalos, M., Marincola, F. M., Miller, J. S., Mostoslavsky, G., Powell, D. J., Rao, M., Restifo, N. P., Rosenberg, S. A., O'Shea, J. & Melief, C. J. M., 15.03.2012, In: J TRANSL MED. 10, p. 48

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. 2011

  45. Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma

    Anderson, L. D., Cook, D. R., Yamamoto, T. N., Berger, C., Maloney, D. G. & Riddell, S. R., 07.2011, In: CANCER IMMUNOL IMMUN. 60, 7, p. 985-97 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells

    Berger, C., Berger, M., Anderson, D. & Riddell, S. R., 04.2011, In: J MED PRIMATOL. 40, 2, p. 88-103 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice

    Wang, X., Berger, C., Wong, C. W., Forman, S. J., Riddell, S. R. & Jensen, M. C., 10.02.2011, In: BLOOD. 117, 6, p. 1888-98 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. 2010

  49. Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging

    Wang, Z., Storb, R., Lee, D., Kushmerick, M. J., Chu, B., Berger, C., Arnett, A., Allen, J., Chamberlain, J. S., Riddell, S. R. & Tapscott, S. J., 03.2010, In: MOL THER. 18, 3, p. 617-24 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. 2009

  51. Safety and immunologic effects of IL-15 administration in nonhuman primates

    Berger, C., Berger, M., Hackman, R. C., Gough, M., Elliott, C., Jensen, M. C. & Riddell, S. R., 17.09.2009, In: BLOOD. 114, 12, p. 2417-26 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Adoptive transfer of virus-specific and tumor-specific T cell immunity

    Berger, C., Turtle, C. J., Jensen, M. C. & Riddell, S. R., 04.2009, In: CURR OPIN IMMUNOL. 21, 2, p. 224-32 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  53. (Updates on) principles of immune cell therapy.

    Berger, S. C. & Riddell, S. R., 2009, Williams Hematology. Kaushansky, K., Lichtman, M. A., Beutler, E., Kipps, T. J., Seligsohn, U. & Prchal, J. T. (eds.). 8th ed. New York: McGraw-Hill, New York, p. 369-378 10 p.

    Research output: SCORING: Contribution to book/anthology › Chapter › Research › peer-review

  54. 2008

  55. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

    Berger, C., Jensen, M. C., Lansdorp, P. M., Gough, M., Elliott, C. & Riddell, S. R., 01.2008, In: J CLIN INVEST. 118, 1, p. 294-305 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. 2007

  57. Genetic modification of T cells for immunotherapy

    Berger, C., Berger, M., Feng, J. & Riddell, S. R., 08.2007, In: EXPERT OPIN BIOL TH. 7, 8, p. 1167-82 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  58. 2006

  59. Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation

    Berger, C., Flowers, M. E., Warren, E. H. & Riddell, S. R., 15.03.2006, In: BLOOD. 107, 6, p. 2294-302 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  60. Adoptive transfer of allogeneic antigen-specific T cells

    Riddell, S. R., Bleakley, M., Nishida, T., Berger, C. & Warren, E. H., 01.2006, In: BIOL BLOOD MARROW TR. 12, 1 Suppl 1, p. 9-12 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  61. Principles of immune cell therapy.

    Berger, S. C. & Riddell, S. R., 2006, Williams Hematology. Beutler, E., Lichtman, M. A., Coller, B. S., Kipps, T. J. & Seligsohn, U. (eds.). 7 ed. McGraw-Hill, New York, p. 323-332 10 p.

    Research output: SCORING: Contribution to book/anthology › Chapter › Research › peer-review

  62. 2004

  63. Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model

    Berger, C., Blau, C. A., Huang, M-L., Iuliucci, J. D., Dalgarno, D. C., Gaschet, J., Heimfeld, S., Clackson, T. & Riddell, S. R., 15.02.2004, In: BLOOD. 103, 4, p. 1261-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  64. 2003

  65. The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation

    Riddell, S. R., Berger, C., Murata, M., Randolph, S. & Warren, E. H., 09.2003, In: BLOOD REV. 17, 3, p. 153-62 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  66. CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy

    Berger, C., Blau, C. A., Clackson, T., Riddell, S. R. & Heimfeld, S., 15.01.2003, In: BLOOD. 101, 2, p. 476-84 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  67. 2001

  68. Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model

    Berger, C., Huang, M. L., Gough, M., Greenberg, P. D., Riddell, S. R. & Kiem, H. P., 01.2001, In: J VIROL. 75, 2, p. 799-808 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  69. 2000

  70. Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes

    Berger, C., Xuereb, S., Johnson, D. C., Watanabe, K. S., Kiem, H. P., Greenberg, P. D. & Riddell, S. R., 05.2000, In: J VIROL. 74, 10, p. 4465-73 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  71. 1999

  72. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts

    Behringer, D., Bertz, H., Schmoor, C., Berger, C., Dwenger, A. & Finke, J., 08.1999, In: BONE MARROW TRANSPL. 24, 3, p. 295-302 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  73. Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors

    Berger, C., Bertz, H., Schmoor, C., Behringer, D., Potthoff, K., Mertelsmann, R. & Finke, J., 05.1999, In: BONE MARROW TRANSPL. 23, 10, p. 983-90 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  74. 1997

  75. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.

    Zander, A. R., Berger, C., Kröger, N., Stockshläder, M., Krüger, W., Horstmann, M., Grimm, J., Zeller, W., Kabisch, H., Erttmann, R., Schönrock, P., Kuse, R., Braumann, D., Illiger, H. J., Fiedler, W., de Witt, M., Hossfeld, K. D. & Weh, H. J., 1997, In: CLIN CANCER RES. 3(12 Pt 2), p. 2671-2675

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next